Salta al contenuto principale

Congresso Nazionale ADOI

Long-Term Efficacy and Safety of Remibrutinib in Patients With Chronic Spontaneous Urticaria in the Phase 3 REMIX-1 and REMIX-2 Studies

Long-Term Efficacy and Safety of Remibrutinib in Patients With Chronic Spontaneous Urticaria in the Phase 3 REMIX-1 and REMIX-2 Studies

Martin Metz,1 Ana Giménez-Arnau,2 Michihiro Hide,3 Vipul Jain,4 Abdallah Khemis,5 Mark Lebwohl,6 Michael Palumbo,7 Sarbjit Saini,8 Ekin Şavk,9 Gordon Sussman,10 Robert Szalewski,11 Irena Walecka Herniczek,12 Hugh Windom,13 Sibylle Haemmerle,14 Karine Lheritier,14 Paula G. P. Machado,15 El-Djouher Martzloff,14 Noriko Seko,16 Pengpeng Wang,17 Artem Zharkov,14 Marcus Maurer11

Orticaria cronica spontanea

Saverio Minervini

non hai trovato il poster che cercavi?